Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Hepatology International
Published in: Hepatology International 1/2018

01-02-2018 | Special Issue - Portal Hypertension

Endoscopic treatments for portal hypertension

Author: Gin-Ho Lo

Published in: Hepatology International | Special Issue 1/2018

Login to get access

Abstract

Acute esophageal variceal hemorrhage is a dreaded complication of portal hypertension. Its management has evolved rapidly in recent years. Endoscopic therapy is often employed to arrest bleeding varices as well as to prevent early rebleeding. The combination of vasoconstrictor and endoscopic therapy is superior to vasoconstrictor or endoscopic therapy alone for control of acute esophageal variceal hemorrhage. After control of acute variceal bleeding, combination of banding ligation and beta-blockers is generally recommended to prevent variceal rebleeding. To prevent the catastrophic event of acute variceal bleeding, endoscopic banding ligation is an important tool in the prophylaxis of first bleeding. Endoscopic obturation with cyanoacrylate is usually utilized to arrest acute gastric variceal hemorrhage as well as to prevent rebleeding. It can be concluded that endoscopic therapies play a pivotal role in management of portal hypertensive bleeding.
Literature
1.
de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5:645–663CrossRefPubMed
2.
3.
Lo GH. The role of endoscopy in secondary prophylaxis of esophageal varices. Clin Liver Dis. 2010;14:307–323CrossRefPubMed
4.
Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652–659CrossRefPubMed
5.
de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846–852CrossRefPubMed
6.
Cheung J, Soo I, Bastiampillai R, Zhu Q, Ma M. Urgent vs. non-urgent endoscopy in stable acute variceal bleeding. Am J Gastroenterol. 2009;104:1125–1129CrossRefPubMed
7.
Hsu YC, Chung CS, Tseng CH, Lin TL, Liou JM, Wu MS, et al. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol. 2009;24:1294–1299CrossRefPubMed
8.
Chen PH, Chen WC, Hou MC, Liu TT, Chang CJ, Liao WC, et al. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study. J Hepatol. 2012;57:1207–1213CrossRefPubMed
9.
Westaby D, Macdougall BRD, Malia W, Theodossi A, William R. A prospective randomized study of two sclerotherapy techniques for oesophageal varices. Hepatology. 1983;3:681–684CrossRefPubMed
10.
11.
12.
Stiegmann GV, Cambre T, Sun JH. A new endoscopic elastic band ligation device. Gastrointest Endosc. 1986;32:230–123CrossRefPubMed
13.
Holderman WH, Etzkorn KP, Patel SA, Harig JM, Watkins JL. Endoscopic findings and overtube-related complications associated with esophageal variceal ligation. J Clin Gastroenterol. 1995;21:91–94CrossRefPubMed
14.
Ramirez FC, Colon VJ, Landan DJ, Grade AJ, Evanich E. The effects of the number of rubber bands placed at each endoscopic session upon variceal outcomes: a prospective, randomized study. Am J Gastroenterol. 2007;102:1372–1376CrossRefPubMed
15.
16.
Wang HM, Lo GH, Chen WC, Chan HH, Tsai WL, Yu HC, et al. Randomized controlled trial of monthly versus biweekly endoscopic variceal ligation for the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol. 2014;29:1229–1236CrossRefPubMed
17.
Sheibani S, Khemichian S, Kim JJ, Hou L, Yan AW, Buxbaum J, et al. Randomized trial of 1-week versus 2-week intervals for endoscopic ligation in the treatment of patients with esophageal variceal bleeding. Hepatology. 2016;64:549–555CrossRefPubMedPubMedCentral
18.
ASGE Standards of Practice Committee. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc. 2014;80:221–227CrossRef
19.
Soehendra N, Nam VC, Grimm H, Kempeneers I. Endoscopic obliteration of large esophagogastric varices with bucrylate. Endoscopy. 1986;18:25–26CrossRefPubMed
20.
Sung JJY, Yeo W, Suen R, Lee TLYT, Chung SCS, Chan FKL, et al. Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulfate. Gastrointest Endosc. 1998;47:235–239CrossRefPubMed
21.
D’Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology. 2003;124:1277–1291CrossRefPubMed
22.
Triantos CK, Goulis J, Patch D, Papatheodoridis GV, Leandro G, Samonakis D, et al. An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy. 2006;38:E74–E90CrossRef
23.
Paquet KJ, Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology. 1985;5:580–583CrossRefPubMed
24.
Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992;326:1527–1532CrossRefPubMed
25.
Laine L, El-Newihi HM, Migikovsky B, Solane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med. 1993;119:1–7CrossRefPubMed
26.
Lo GH, Lai KH, Cheng JS, Hwu JH, Chang CF, Chen SM, et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology. 1995;22:466–471CrossRefPubMed
27.
Sarin SK, Govil A, Jain AK, Guptan RC, Issar SK, Jain M, et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol. 1997;26:826–832CrossRefPubMed
28.
Hou MC, Lin HC, Kuo BI, Chen CH, Lee FY, Lee SD. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology. 1995;21:1517–1522PubMed
29.
Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med. 1995;123:280–287CrossRefPubMed
30.
Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology. 1997;25:1101–1104CrossRefPubMed
31.
Avgerinos A, Armonis A, Stefanidis G, Mathou N, Vlachogiannakos J, Kougioumtzian A, et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology. 2004;39:1623–1630CrossRefPubMed
32.
Laine L, Planas R, Nevens F, Rafael Bañares, David Patch Jaime Bosch. Treatment of the acute bleeding episode. In: de Franchis R. Portal hypertension IV: proceedings of the fourth Baveno International Consensus Workshop. Blackwell Publishing 2006; p 217–242
33.
Chen WC, Lo GH, Tsai WL, Hsu PI, Lin CK, Lai KH. Emergency endoscopic variceal ligation versus somatostatin for acute esophageal variceal bleeding. J Chin Med Assoc. 2006;69:60–67CrossRefPubMed
34.
Banares R, Albillos A, Rincon D, Alonso S, Gonzalez M, Ruiz-del-Arbol L, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment of acute variceal bleeding: a meta-analysis. Hepatology. 2002;35:609–615CrossRefPubMed
35.
Lo GH, Chen WC, Wang HM, Lin CK, Tsai WL, et al. Low-dose terlipressin plus banding ligation vs. low-dose terlipressin alone in the prevention of very early rebleeding of esophageal varices. Gut. 2009;58:1275–1280CrossRefPubMed
36.
Villanueva C, Piqueras M, Aracil C, Gomez C, López-Balaguer JM, Gonzalez B, et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006;45:560–567CrossRefPubMed
37.
de Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Sem Liver Dis. 1999;19:439–455CrossRef
38.
Lo GH, Lai KH, Shen MT, Chang CF. A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices. Gastrointest Endosc. 1994;40:675–679PubMed
39.
Hou MC, Lin HC, Lee FY, Chang FY, Lee SD. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation. J Hepatol. 2000;32:202–208CrossRefPubMed
40.
Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol. 1997;26:312–324CrossRefPubMed
41.
Villanueva C, Balanzo J, Novella MT, Soriano G, Sáinz S, Torras X, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 1996;334:1624–1629CrossRefPubMed
42.
Villanueva C, Minyana J, Ortiz J, Gallego A, Soriano G, Torras X, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal rebleeding. N Engl J Med. 2001;345:647–655CrossRefPubMed
43.
Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, et al. A prospective, randomized trial of endoscopic variceal ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology. 2002;123:728–734CrossRefPubMed
44.
Patch D, Sabin CA, Goulis J, Gerunda G, Greenslade L, Merkel C, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology. 2002;123:1013–1019CrossRefPubMed
45.
Romero G, Kravetz D, Argonz J, Vulcano C, Suarez A, Fassio E, et al. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Aliment Pharmacol Ther. 2006;24:601–611CrossRefPubMed
46.
Sarin SK, Wadhawan M, Gupta R, Shahi H. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci. 2005;50:1538–1547CrossRefPubMed
47.
Ahmad I, Khan AA, Alam A, Butt AK, Shafqat F, Sarwar S. Propranolol, isosorbide mononitrate and endoscopic band ligation—alone or in varying combinations for the prevention of esophageal variceal rebleeding. JCPSP. 2009;19:283–286PubMed
48.
Garcia-Pagan JC, Bosch J. Endoscopic band ligation in the treatment of portal hypertension. NCP Gastroenterol Hepatol. 2005;2:526–535
49.
Lo GH, Chen WC, Lin CK, Tsai WL, Chan HH, Chen TA, et al. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology. 2008;48:580–587CrossRefPubMed
50.
Lo GH, Lai KH, Cheng JS, Huang RL, Wang SJ, Chiang HT. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy. Gastrointest Endosc. 1999;49:428–436CrossRefPubMed
51.
Singh P, Pooran N, Indaram A, Bank S. Combined ligation and sclerotherapy versus ligation alone for secondary prophylaxis of esophageal variceal bleeding: a meta-analysis. Am J Gastroenterol. 2002;97:623–629CrossRefPubMed
52.
Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, et al. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: a prospective, randomized trial. Hepatology. 1998;28:391–395CrossRefPubMed
53.
Cheng YS, Pan S, Lien GS, Suk FM, Wu MS, Chen JN, et al. Adjuvant sclerotherapy after ligation for the treatment of esophageal varices: a prospective, randomized long-term study. Gastrointest Endosc. 2001;53:566–571CrossRefPubMed
54.
Nakamura S, Mitsunaga A, Murata Y, Suzuki S, Hayashi N. Endoscopic induction of mucosal fibrosis by argon plasma coagulation (APC) for esophageal varices: a prospective randomized trial of ligation plus APC vs. ligation alone. Endoscopy. 2001;33:210–215CrossRefPubMed
55.
Cipolletta L, Bianco MA, Rotondano G, Marmo R, Meucci C, Piscopo R. Argon plasma coagulation prevents variceal recurrence after band ligation of esophageal varices: preliminary results of a prospective randomized trial. Gastrointest Endosc. 2002;56:467–471CrossRefPubMed
56.
Lo GH, Lai KH, Cheng JS, Chen MH, Huang HC, Hsu PI, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000;32:461–465CrossRefPubMed
57.
De la Pena J, Brullet E, Sanchez-Hernandez E, Rivero M, Vergara M, Martin-Lorente JL, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology. 2005;41:572–578CrossRefPubMed
58.
Gonzalez R, Zamora J, Gomez-Camarero J, Molinero LM, Bañares R, Albillos A. Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med. 2008;15(149):109–122CrossRef
59.
Lo GH, Chen WC, Chen MH, Tsai WL, Hsu PI, Lin CK, et al. A randomized, controlled trial of banding ligation plus drug therapy vs drug therapy alone in the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol. 2009;24:982–987CrossRefPubMed
60.
Puente A, Hernandez-Gea V, Graupera I, Roque M, Colomo A, Poca M, et al. Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver Int. 2014;34:823–833CrossRefPubMed
61.
Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Tisnado J, et al. Transjugular intrahepatic portosystemic stent shunt compared with endoscopic therapy for the prevention of recurrent variceal hemorrhage: a randomized, controlled trial. Ann Intern Med. 1997;126:849–857CrossRefPubMed
62.
Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology. 1997;26:1115–1122PubMed
63.
Papatheodoridis G, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding. Heptology. 1999;30:612–622CrossRef
64.
Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001;120:726–748CrossRefPubMed
65.
de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, et al. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology. 2008;47:1595–1603CrossRefPubMed
66.
Wang HM, Lo GH, Chen WC, Hsu PI, Yu HC, Lin CK, et al. Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosis. J Dig Dis. 2012;13:430–438CrossRefPubMed
67.
The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. N Engl J Med. 1991;324:1779–1784CrossRef
68.
Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology. 2001;33:802–807CrossRefPubMed
69.
Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for primary prevention of variceal bleeding. N Engl J Med. 1999;340:988–993CrossRefPubMed
70.
Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc. 2004;59:333–338CrossRefPubMed
71.
Schepke M, Kleber G, Niirnberg D, Willert J, Koch L, Wilfried VS, et al. Ligation vs. propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004;40:65–72CrossRefPubMed
72.
Jutabha R, Jensen DM, Martin P, Savides T, Han S-H, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high risk esophageal varices. Gastroenterology. 2005;128:870–881CrossRefPubMed
73.
Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther. 2005;21:347–361CrossRefPubMed
74.
Tripathi D, Ferguson JW, Kochar N, Leithead JA, Therapondos G, Mcavoy N, et al. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleeding. Hepatology. 2009;50:825–833CrossRefPubMed
75.
Svoboda P, Kantorova I, Ochmann J, Kozumplik L, Marsova J. A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices. Surg Endosc. 1999;13:580–584CrossRefPubMed
76.
Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC. Endoscopic variceal ligation plus propranolol vs. endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol. 2005;100:797–804CrossRefPubMed
77.
Lo GH, Chen WC, Wang HM, Lee CC. A controlled trial of ligation plus nadolol vs. nadolol alone for the prevention of first variceal bleeding. Hepatology. 2010;52:230–237CrossRefPubMed
78.
Sarin SK, Primignani M, Agarwal SR. Gastric varices. In: de Franchis R, editor. Portal hypertension III. In: Proceedings of the third Baveno International Consensus Workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell, Science 2001; 76–96
79.
Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc. 1986;32:264–268CrossRefPubMed
80.
Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in management of bleeding gastric varices. Hepatology. 2001;33:1060–104CrossRefPubMed
81.
Tan PC, Hou MC, Lin HC, Liu TT, Lee FY, Chang FY, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology. 2006;43:690–697CrossRefPubMed
82.
Tantau M, Crisan D, Popa D, Vesa S, Tantau A. Band ligation vs. N-butyl-2-cyanoacrylate injection in acute gastric variceal bleeding: a prospective follow-up study. Ann Hepatol. 2013;13:75–83PubMed
83.
Qiao W, Ren Y, Bai Y, Liu S, Zhang Q, Zhi F. Cyanoacrylate injection versus band ligation in the endoscopic management of acute gastric variceal bleeding: meta-analysis of randomized, controlled studies based on the PRISMA statement. Medicine (Baltimore). 2015;94:e1725CrossRef
84.
Garcia-Pagan JC, Barrufet M, Cardenas A, Escorsell A. Management of gastric varices. Clin Gastroenterol Hepatol. 2014;12:919–928CrossRefPubMed
85.
Lo GH, Lai KH. Should GOV1 be treated as for esophageal varices? Gastroenterology. 2004;127:1014–105 (letter) CrossRefPubMed
86.
Lo GH, Lin CW, Perng DS, Chang CY, Lee CT, Hsu CY, et al. A retrospective comparative study of histoacryl injection and banding ligation in the treatment of acute type 1 gastric variceal hemorrhage. Scand J Gastroenterol. 2013;48:1198–1204CrossRefPubMed
87.
Hung HH, Chang CJ, Hou MC, Liao WC, Chan CC, Huang HC, et al. Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol. 2012;56:1025–1032CrossRefPubMed
88.
Mahadeva S, Bellamy MC, Kessel D, Davies MH, Millson CE. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol. 2003;98:2688–2693CrossRefPubMed
89.
Procaccini NJ, Al-Osaimi AM, Northup P, Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc. 2009;70:881–887CrossRefPubMed
90.
Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt vs. cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy. 2007;39:679–685CrossRefPubMed
91.
Bai M, Qi XS, Yang ZP, Wu KC, Fan DM, Han GH. EVS vs TIPS shunt for gastric variceal bleeding in patients with cirrhosis: a meta-analysis. World J Gastrointest Pharmacol Ther. 2014;5:97–104CrossRefPubMedPubMedCentral
92.
McAvoy NC, Plevris JN, Hayes PC. Human thrombin for the treatment of gastric and ectopic varices. World J Gastroenterol. 2012;7:5912–5917CrossRef
93.
Mishra SR, Sharma BC, Kumar A, Sarin SK. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol. 2011;54:1161–1167CrossRefPubMed
94.
Gunnerson AC, Diehl DL, Nguyen VN, Shellenberger MJ, Blansfield J. Endoscopic duodenal variceal ligation: a series of 4 cases and review of the literature. Gastrointest Endosc. 2012;76:900–904CrossRefPubMed
95.
Sato T, Yamazaki K, Akaike J, Toyota J, Karino Y, Ohmura T. Retrospective analysis of endoscopic injection sclerotherapy for rectal varices compared with band ligation. Clin Exp Gastroenterol. 2010;3:159–163CrossRefPubMedPubMedCentral
96.
Schafer TW, Binmoeller KF. Argon plasma coagulation for the treatment of colonic varices. Endoscopy. 2002;34:661–663CrossRefPubMed
97.
Lo GH, Lai KH, Cheng JS, Hsu PI, Chen TA, Wang EM, et al. The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective controlled trial. Gastrointest Endosc. 2001;53:579–584CrossRefPubMed
98.
Sarin SK, Streenlvas DV, Lahoti D, Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology. 1992;102:994–999CrossRefPubMed
99.
Patwardhan VR, Cardenas A. The management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis. Aliment Pharmacol Ther. 2014;40:354–362CrossRefPubMed
100.
Smith LA, Morris AJ, Stanley AJ. The use of hemospray in portal hypertensive bleeding: a case series. J Hepatol. 2014;60:457–460CrossRefPubMed
Metadata
Title
Endoscopic treatments for portal hypertension
Author
Gin-Ho Lo
Publication date
01-02-2018
Publisher
Springer India
Published in
Hepatology International / Issue Special Issue 1/2018
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-017-9828-8

Other articles of this Special Issue 1/2018

Hepatology International 1/2018 Go to the issue

Special Issue - Portal Hypertension

Pharmacologic prevention of variceal bleeding and rebleeding

Special Issue - Portal Hypertension

Acute variceal bleeding: risk stratification and management (including TIPS)

Special Issue - Portal Hypertension

Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon

Special Issue - Portal Hypertension

Hepatic encephalopathy: a critical current review

Special Issue - Portal Hypertension

Idiopathic portal hypertension and extrahepatic portal venous obstruction

Special Issue - Portal Hypertension

Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits